Poster 39

Change in quality-of-life measurements (QoL) following 12 week treatment with a novel topical isotretinoin formulation (TMB-001) in participants with severe X-Linked Ichthyosis (XLRI) or Autosomal Recessive Congenital Ichthyosis (ARCI-LI) at baseline: Phase 2b CONTROL study results

Authors: Leslie Castelo-Soccio, Joyce Teng, Scott Guenthner, Kalyani Marathe, Steven Kempers, Kimmie Eads, Dedee F. Murrell, Alan M. Mendelsohn, Jessica Raiz, Christopher G. Bunick

<PREVIOUS POSTER | NEXT POSTER>

Poster 39